Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

The advent of automated insulin delivery (AID) systems in 2020 marked a disruptive event in managing type 1 diabetes, benefiting children and adults alike. By 2024, advances in real-world data and research motivated an update to the French consensus on AID systems to expand accessibility, refine guidelines, and optimize patient follow-up. AID systems have consistently improved glycemic control by reducing HbA1c, increasing time-in-range (TIR), and minimizing hypoglycemia, with significant benefits even for specific populations such as individuals with poor glycemic control, brittle diabetes, children, very young children, pregnant women, those with insulin resistance or gastroparesis, or after bariatric surgery.

Legal landscape and a few case studies of natural products' sales in India: challenges and resolutions.

This review examines India's legal framework governing natural product sales, focusing on challenges and solutions. It analyses key legislation, including the Drugs and Cosmetics Act, Food Safety and Standards Act, and Biological Diversity Act, while addressing jurisdictional overlaps among bodies like FSSAI and CDSCO. Case studies highlight intellectual property disputes, quality control, mislabelling, false advertising, and unauthorised sales, emphasising consumer safety and public health.

Descriptive Report of Injuries Sustained by Secondary School Baseball Players Categorized by Community-Level of Socioeconomic Status.

Context: Baseball is a popular sport in the United States, with widespread play among secondary school student-athletes. Baseball-related injuries may vary based on community-level socioeconomic status of schools. Objective: To describe the injuries sustained by secondary school baseball players from schools categorized by community-level socioeconomic status.

Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands.

Background/purpose: Proton radiation-therapy (PrT) may provide clinical benefit for lung cancer compared to photon radiation-therapy (PhT), however is more costly. Literature reporting costs for PrT, PhT, and comparisons thereof, particularly from a societal perspective, are scarce. This study aims to provide an adaptable framework to estimate PrT/PhT costs, demonstrated through application to lung cancer, from societal and healthcare perspectives.